COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

CATEGORIES: General SLE

This randomized, multi-site, adaptive, open-label clinical trial will compare the immune response to different COVID-19 vaccine booster doses in participants with autoimmune disease requiring immunosuppressive medications.

To Learn More Contact
Judith A. James, MD, PhD, Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation
Meggan C. Mackay, MD, MS, Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research
ClinicalTrials.gov identifier: NCT05000216